Skip to content

Clinical trials

Phase 1/2 Endometrial Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 1/2 Country / region: Italy Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20162
20171
20181
20193
20202
20212
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Completed3
Active, not recruiting2
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Novartis Pharmaceuticals2
Clovis Oncology, Inc.1
Daiichi Sankyo1
Eikon Therapeutics1
Eisai Inc.1
Eli Lilly and Company1
Genmab1
GlaxoSmithKline1
Mundipharma Research Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms16
Ovarian Neoplasms10
Colorectal Neoplasms7
Neoplasms7
Breast Neoplasms6
Neoplasm Metastasis4
Uterine Cervical Neoplasms4
Carcinoma, Non-Small-Cell Lung3
Fallopian Tube Neoplasms3
Neoplasms by Site3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.